U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07006012) titled 'RGL-305+ Lymphoma + Exploratory Clinical Study' on May 02.
Brief Summary: This study is an open, prospective, dose-increasing exploratory clinical trial. To evaluate the safety, cytodynamics and initial efficacy of RGL-305 in patients with lymphoma. All enrolled lymphoma patients were required to achieve CR or PR and MRD positive after standard treatment, PR patients were required to have a Deauville score of 4, and all patients would receive RGL-305 cell reinfusion therapy.
Study Start Date: April 21
Study Type: INTERVENTIONAL
Condition:
Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatm...